Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis have?
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis has 944 citations in the OpenAlex counts ScholarIQ stores.
When was Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis published?
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis has 2012 year in the ScholarIQ index.
What is the open-access status of Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis?
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis has bronze oa status in the ScholarIQ index.
What is the DOI of Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis?
The DOI for Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis is on the source record.
What is the PMID of Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis?
The PMID for Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis is on the source record.
What is the OpenAlex record for Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis?
The OpenAlex for Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis is on the source record.